- •Anemia
- •Syndromes in anemia
- •Definition of anemia
- •Risk factors for anemia
- •Classification of anemia
- •Classification of anemia
- •Classification by severity
- •Symptoms and signs of anemia
- •Initial investigations in anemia
- •Iron deficiency anemia
- •Causes of iron-deficiency anemia
- •Syndromes in IDA
- •Symptoms of iron deficiency
- •Clinical presentation of IDA
- •Diagnostics of IDA
- •Poikilocytosis
- •Iron metabolism parameters and CBC changes in iron deficiency
- •Bone marrow in iron deficiency
- •Additional tests for differential diagnostics in IDA
- •Management of IDA
- •Megaloblastic anemia
- •Daily need in B12 and folic acid
- •Vitamin B12 absorption and transport.
- •Classification Of The Megaloblastic Anemias
- •Classification Of The Megaloblastic Anemias
- •B12 deficiency: pathogenesis of symptoms
- •Clinical presentation of megaloblastic anemia
- •Funicular myelosis
- •Diagnostics
- •Peripheral blood smear in megaloblastic anemia
- •Treatment
- •Response to therapy with B12 – reticulocytosis within 7-10 days
- •Hemolytic anemia
- •Pathogenesis of hemolytic anemia
- •Classification of hemolytic anemia
- •Mechanisms of different types of hemolysis
- •Classification Of Disorders Due To Hemoglobin Abnormalities
- •Hemolysis Due To Antibodies
- •Drugs Causing Hemolysis In Subjects
- •Clinical presentation
- •Diagnostics
- •Principles of treatment
- •Aplastic anemia
- •Clinical presentation of aplastic anemia
- •Pancytopenia
- •Aplastic anemia treatment
Bone marrow in iron deficiency
Additional tests for differential diagnostics in IDA
•Reticulocytes
•Hemosiderinuria
•Hemoglobinuria
•Hb electrophoresis
•HbA2 level
•Search for the possible sources of chronic blood loss and malabsorbtion
Management of IDA
Megaloblastic anemia
•Megaloblastosis describes a heterogeneous group of disorders that share common morphologic characteristics: large cells with an arrest in nuclear maturation.
•Cause: impaired DNA synthesis and, to a lesser extent, RNA and protein synthesis.
–B12 deficiency
–Folate deficiency
•Most apparent in rapidly dividing cells such as blood cells and gastrointestinal cells.
Daily need in B12 and folic acid
B12
•Need: 5-7 μg
•In storage: 3 mg
•Symptoms develop within 3-5 years after gastrectomy Folic acid
•Need: 400 μg
•In storage: 1-2 mg
•Symptoms develop within 3-4 weeks after folate intake is stopped
Vitamin B12 absorption and transport.
Classification Of The Megaloblastic Anemias
COBALAMIN DEFICIENCY
I. Inadequate intake: vegetarians (rare)
II.Malabsorption
A.Inadequate production of intrinsic factor (IF)
1.Pernicious anemia
2.Gastrectomy
3.Congenital absence or functional abnormality of IF (rare)
B.Disorders of terminal ileum
1.Tropical sprue
2.Nontropical sprue
3.Regional enteritis
4.Intestinal resection
5.Neoplasms and granulomatous disorders (rare)
6.Selective cobalamin malabsorption (Imerslund's syndrome) (rare)
C.Competition for cobalamin
1.Fish tapeworm
2.Bacteria: "blind loop" syndrome
D.Drugs: p-aminosalicylic acid, colchicine, neomycin
III.Other
A.Nitrous oxide
B.Transcobalamin II deficiency (rare)
Classification Of The Megaloblastic Anemias
FOLIC ACID DEFICIENCY
I.Inadequate intake: unbalanced diet (common in alcoholics, teenagers, some infants)
II.Increased requirements
A.Pregnancy
B.Infancy
C.Malignancy
D.Increased hematopoiesis (chronic hemolytic anemias)
E.Chronic exfoliative skin disorders
F.Hemodialysis
III.Malabsorption
A.Tropical sprue
B.Nontropical sprue
C.Drugs: Phenytoin, barbiturates, (?) ethanol IV. Impaired metabolism
A.Inhibitors of dihydrofolate reductase: methotrexate, pyrimethamine, triamterene, pentamidine, trimethoprim
B.Alcohol
C.Rare enzyme deficiencies: dihydrofolate reductase, others